Successful Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline.

Related Articles

Successful Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline.

J Drugs Dermatol. 2021 Jan 01;20(1):98-100

Authors: Graber E, Kay CR

Abstract
Broad spectrum tetracyclines are a well-known, widely used, and often successful treatment for use in inflammatory skin pathologies such as acne and rosacea. However, the steady rise of antibiotic resistance and gut dysbiosis associated with broad spectrum tetracyclines emphasizes the importance and responsibility of antibiotic stewardship. Narrow spectrum antibiotics have become increasingly important therapies to slow the progression of resistance as well as decrease negative side effect profiles, particularly those associated with broad spectrum tetracyclines. This case shows the successful treatment of periorificial dermatitis with a novel, narrow spectrum tetracycline, sarecycline, in a patient with underlying Crohn’s. J Drugs Dermatol. 2021;20(1):98-100. doi:10.36849/JDD.2021.5678.

PMID: 33400418 [PubMed - as supplied by publisher]